|
1
|
Obermair A, Beale P, Scott CL, Beshay V,
Kichenadasse G, Simcock B, Nicklin J, Lee YC, Cohen P and Meniawy
T: Insights into ovarian cancer care: report from the ANZGOG
ovarian cancer webinar series 2020. J Gynecol Oncol. 32:e952021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xia CF, Dong XS, Li H, Cao M, Sun D, He S,
Yang F, Yan X, Zhang S, Li N and Chen W: Cancer statistics in China
and United States, 2022: Profiles, trends, and determinants. Chin
Med J (Engl). 135:584–590. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Garrido MP, Fredes AN, Lobos-Gonzalez L,
Valenzuela-Valderrama M, Vera DB and Romero C: Current treatments
and new possible complementary therapies for epithelial ovarian
cancer. Biomedicines. 10:772021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jayde V, White K and Blomfield P: Symptoms
and diagnostic delay in ovarian cancer: A summary of the
literature. Contemp Nurse. 34:55–65. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Konstantinopoulos PA and Matulonis UA:
Clinical and translational advances in ovarian cancer therapy. Nat
Cancer. 4:1239–1257. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Orr JA and Hamilton PW: Histone
acetylation and chromatin pattern in cancer. A review. Anal Quant
Cytol Histol. 29:17–31. 2007.PubMed/NCBI
|
|
7
|
Makowski AM, Dutnall RN and Annunziato AT:
Effects of acetylation of histone H4 at lysines 8 and 16 on
activity of the Hat1 histone acetyltransferase. J Biol Chem.
276:43499–43502. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jin X, Tian SH and Li PP: Histone
acetyltransferase 1 promotes cell proliferation and induces
cisplatin resistance in hepatocellular carcinoma. Oncol Res.
25:939–946. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Klett-Mingo JI, Pinto-Díez C,
Cambronero-Plaza J, Carrión-Marchante R, Barragán-Usero M,
Pérez-Morgado MI, Rodríguez-Martín E, Toledo-Lobo MV, González VM
and Martín ME: Potential therapeutic use of aptamers against HAT1
in lung cancer. Cancers (Basel). 15:2272022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xue L, Hou J, Wang Q, Yao L, Xu S and Ge
D: RNAi screening identifies HAT1 as a potential drug target in
esophageal squamous cell carcinoma. Int J Clin Exp Patho.
7:3898–3907. 2014.PubMed/NCBI
|
|
11
|
Sarkar T, Dhar S, Chakraborty D, Pati S,
Bose S, Panda AK, Basak U, Chakraborty S, Mukherjee S, Guin A, et
al: FOXP3/HAT1 axis controls treg infiltration in the tumor
microenvironment by inducing CCR4 expression in breast cancer.
Front Immunol. 13:7405882022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun Y, Ren D, Zhou Y, Shen J, Wu H and Jin
X: Histone acetyltransferase 1 promotes gemcitabine resistance by
regulating the PVT1/EZH2 complex in pancreatic cancer. Cell Death
Dis. 12:8782021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang G, Yuan Y, Yuan H, Wang J, Yun H,
Geng Y, Zhao M, Li L, Weng Y, Liu Z, et al: Histone
acetyltransferase 1 is a succinyltransferase for histones and
non-histones and promotes tumorigenesis. Embo Rep. 22:e509672021.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Weidemüller P, Kholmatov M, Petsalaki E
and Zaugg JB: Transcription factors: Bridge between cell signaling
and gene regulation. Proteomics. 21:e20000342021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hanahan D: Hallmarks of cancer: New
dimensions. Cancer Discov. 12:31–46. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI
|
|
18
|
Webb PM and Jordan SJ: Epidemiology of
epithelial ovarian cancer. Best Pract Res Clin Obstet Gynaecol.
41:3–14. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shirvaliloo M: The landscape of histone
modifications in epigenomics since 2020. Epigenomics. 14:1465–1477.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shvedunova M and Akhtar A: Modulation of
cellular processes by histone and non-histone protein acetylation.
Nat Rev Mol Cell Bio. 23:329–349. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun LC, Zhang HF and Gao P: Metabolic
reprogramming and epigenetic modifications on the path to cancer.
Protein Cell. 13:877–919. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fan P, Zhao J, Meng Z, Wu H, Wang B, Wu H
and Jin X: Overexpressed histone acetyltransferase 1 regulates
cancer immunity by increasing programmed death-ligand 1 expression
in pancreatic cancer. J Exp Clin Cancer Res. 38:472019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gruber JJ, Geller B, Lipchik AM, Chen J,
Salahudeen AA, Ram AN, Ford JM, Kuo CJ and Snyder MP: HAT1
coordinates histone production and acetylation via H4 promoter
binding. Mol Cell. 75:711–724.e5. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Carroll JS, Liu XS, Brodsky AS, Li W,
Meyer CA, Szary AJ, Eeckhoute J, Shao W, Hestermann EV, Geistlinger
TR, et al: Chromosome-wide mapping of estrogen receptor binding
reveals long-range regulation requiring the forkhead protein FoxA1.
Cell. 122:33–43. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cirillo LA, Lin FR, Cuesta I, Friedman D,
Jarnik M and Zaret KS: Opening of compacted chromatin by early
developmental transcription factors HNF3 (FoxA) and GATA-4. Mol
Cell. 9:279–289. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cirillo LA and Zaret KS: An early
developmental transcription factor complex that is more stable on
nucleosome core particles than on free DNA. Mol Cell. 4:961–969.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Laganière J, Deblois G, Lefebvre C,
Bataille AR, Robert F and Giguère V: From the Cover: Location
analysis of estrogen receptor alpha target promoters reveals that
FOXA1 defines a domain of the estrogen response. Proc Natl Acad Sci
USA. 102:11651–11656. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zaret K: Developmental competence of the
gut endoderm: Genetic potentiation by GATA and HNF3/fork head
proteins. Dev Biol. 209:1–10. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Albergaria A, Paredes J, Sousa B, Milanezi
F, Carneiro V, Bastos J, Costa S, Vieira D, Lopes N, Lam EW, et al:
Expression of FOXA1 and GATA-3 in breast cancer: The prognostic
significance in hormone receptor-negative tumours. Breast Cancer
Res. 11:R402009. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
He Y, Wang L, Wei T, Xiao YT, Sheng H, Su
H, Hollern DP, Zhang X, Ma J, Wen S, et al: FOXA1 overexpression
suppresses interferon signaling and immune response in cancer. J
Clin Invest. 131:e1470252021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Abe Y, Ijichi N, Ikeda K, Kayano H,
Horie-Inoue K, Takeda S and Inoue S: Forkhead box transcription
factor, forkhead box A1, shows negative association with lymph node
status in endometrial cancer, and represses cell proliferation and
migration of endometrial cancer cells. Cancer Sci. 103:806–812.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Agudelo Garcia PA, Lovejoy CM, Nagarajan
P, Park D, Popova LV, Freitas MA and Parthun MR: Histone
acetyltransferase 1 is required for DNA replication fork function
and stability. J Biol Chem. 295:8363–8373. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang X, Li L, Liang J, Shi L, Yang J, Yi
X, Zhang D, Han X, Yu N and Shang Y: Histone acetyltransferase 1
promotes homologous recombination in DNA repair by facilitating
histone turnover. J Biol Chem. 288:18271–18282. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Agudelo Garcia PA, Hoover ME, Zhang P,
Nagarajan P, Freitas MA and Parthun MR: Identification of multiple
roles for histone acetyltransferase 1 in replication-coupled
chromatin assembly. Nucleic Acids Res. 45:9319–9335. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kelman Z and O'Donnell M: Structural and
functional similarities of prokaryotic and eukaryotic DNA
polymerase sliding clamps. Nucleic Acids Res. 23:3613–3620. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Taftachi R, Ayhan A, Ekici S, Ergen A and
Ozen H: Proliferating-cell nuclear antigen (PCNA) as an independent
prognostic marker in patients after prostatectomy: A comparison of
PCNA and Ki-67. BJU Int. 95:650–654. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tan Z, Wortman M, Dillehay KL, Seibel WL,
Evelyn CR, Smith SJ, Malkas LH, Zheng Y, Lu S and Dong Z:
Small-molecule targeting of proliferating cell nuclear antigen
chromatin association inhibits tumor cell growth. Mol Pharmacol.
81:811–819. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xiong Y, Zhang H and Beach D: D type
cyclins associate with multiple protein kinases and the DNA
replication and repair factor PCNA. Cell. 71:505–514. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Koundrioukoff S, Jónsson ZO, Hasan S, de
Jong RN, van der Vliet PC, Hottiger MO and Hübscher U: A direct
interaction between proliferating cell nuclear antigen (PCNA) and
Cdk2 targets PCNA-interacting proteins for phosphorylation. J Biol
Chem. 275:22882–22887. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Suski JM, Braun M, Strmiska V and Sicinski
P: Targeting cell-cycle machinery in cancer. Cancer Cell.
39:759–778. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cavalu S, Abdelhamid AM, Saber S, Elmorsy
EA, Hamad RS, Abdel-Reheim MA, Yahya G and Salama MM: Cell cycle
machinery in oncology: A comprehensive review of therapeutic
targets. FASEB J. 38:e237342024. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhou P, Peng X, Zhang K, Cheng J, Tang M,
Shen L, Zhou Q, Li D and Yang L: HAT1/HDAC2 mediated ACSL4
acetylation confers radiosensitivity by inducing ferroptosis in
nasopharyngeal carcinoma. Cell Death Dis. 16:1602025. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gaddameedi JD, Chou T, Geller BS,
Rangarajan A, Swaminathan TA, Dixon D, Long K, Golder CJ, Vuong VA,
Banuelos S, et al: Acetyl-click screening platform identifies
small-molecule inhibitors of histone acetyltransferase 1 (HAT1). J
Med Chem. 66:5774–5801. 2023. View Article : Google Scholar : PubMed/NCBI
|
